Eli Lilly
LLY · NYSE · Healthcare · Pharmaceuticals · Metabolic & Neuro
LIVE MARKET DATA NOT YET CONNECTED — price, movement, and market cap will appear here with source and timestamp once a data provider is integrated.
Red Cardinal Snapshot
WHAT IT DOES
Eli Lilly discovers, manufactures, and sells medicines — above all tirzepatide, the GLP-1 drug sold as Mounjaro for diabetes and Zepbound for obesity, plus a deep bench in Alzheimer's, oncology, and immunology.
HOW IT MAKES MONEY
By selling prescription drugs, mostly through insurers and pharmacy middlemen rather than directly to patients. The metabolic franchise now carries the company: every filled Mounjaro or Zepbound script is revenue, which is why the ability to physically make enough doses matters as much as the science.
WHY WE TRACK IT
GLP-1s are the biggest structural shock to healthcare, food, and consumer behavior in a generation — obesity treated as a chronic condition at population scale. Lilly sits at the source of that shock, so its trajectory ripples through insurers, grocers, restaurants, and anyone whose business model assumed people eat the way they used to.
THE SIMPLE THESIS
Lilly won the potency race in the biggest drug market ever, then converted a scientific lead into an industrial one — building manufacturing capacity at semiconductor-fab scale because whoever can make the doses wins the scripts. The question is whether pricing, politics, and competition erode the franchise before it finishes compounding.
PREMIUM RESEARCH
The rest of the Eli Lilly dossier
The Five Minute Brief, our intelligence rating and thesis health, the competitive position, the bull and bear cases, what would invalidate the thesis, and every source behind it.
- Five Minute Brief
- Intelligence rating and thesis health
- Competitive position and moat analysis
- Bull case, bear case, and what breaks it
- Systemic importance and cascade effects
- Full source list and methodology
Subscribe to the newsletter and choose 3 dossiers to read in full — this one included, if you like.
Free, and you pick the companies. No card required.